Results 221 to 230 of about 260,495 (313)

Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy

Cancer Science, EarlyView.
ICI‐included therapies are standard for R/M HNSCC patients. In particular, neoadjuvant ICI therapy shows promising clinical results even in nontreated resectable HNSCC patients. In addition, cancer vaccine, immune cell‐based therapy, immunomodulation therapy, and TME targeting therapy may combine with ICI.
Hirofumi Shibata, Masashi Kuroki, Ryo Kawaura, Tatsuhiko Yamada, Ryota Iinuma, Hiromasa Ishihara, Hiroshi Okuda, Kenichi Mori, Takenori Ogawa   +8 more
wiley   +1 more source

Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infections

, 1991
Peter J.F. Snijders, Chris J.L.M. Meijer, Jan M.M. Walboomers   +2 more
openalex   +1 more source

Design and Evaluation of Eb4Mab‐7‐mG2a: A Dual‐Action Anti‐EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy

Cancer Science, EarlyView.
Eb4Mab‐7‐mG2a, an anti‐EphB4 monoclonal antibody, significantly suppressed tumor growth in the MCF‐7 xenograft model. Tumor volume and weight were markedly reduced in treated mice, demonstrating its antitumor efficacy against EphB4‐positive breast cancer.
Tomokazu Ohishi, Hiroyuki Suzuki, Mika K. Kaneko, Tomohiro Tanaka, Akiko Harakawa, Junjiro Yoshida, Daisuke Tatsuda, Yukinari Kato, Manabu Kawada   +8 more
wiley   +1 more source

The necessity and challenges of human papillomavirus testing for men. [PDF]

Front Cell Infect Microbiol
Ren W, Jin Y, Shi L, Chen H, Zhang Z, Wang Y, Zhai T, Huang J.   +7 more
europepmc   +1 more source

Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein [PDF]

, 1992
William C. Phelps, Karl Münger, Carole Yee, J. Barnes, Peter M. Howley   +4 more
openalex   +1 more source

VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix

Cancer Science, EarlyView.
Small cell neuroendocrine carcinoma of the cervix (SCNEC), a rare but aggressive cancer, consistently exhibited high VRK1 expression. VRK1 knockdown significantly suppressed xenograft tumor growth by inducing mitochondrial dysfunction. These findings highlighted VRK1 as a potential therapeutic target for SCNEC.
Mariya Kobayashi, Satoshi Nakagawa, Yusuke Ishii, Yuji Kamei, Mizuki Kanda, Tatsuo Masuda, Mamoru Kakuda, Kosuke Hiramatsu, Tadashi Iwamiya, Tomomi Egawa‐Takata, Shinya Matsuzaki, Hiroyuki Uematsu, Kunishige Onuma, Masahiro Inoue, Yutaka Ueda, Tadashi Kimura, Michiko Kodama   +16 more
wiley   +1 more source

Summary of final data from the 9-valent human papillomavirus vaccine pregnancy registry (2014-2021). [PDF]

Hum Vaccin Immunother
Hardalo C, Marko A, Sciba B, Rausch D, Sieger B, Leong R, Tota JE, Luxembourg A, Kaplan SS.   +8 more
europepmc   +1 more source

Comparative Cytokine and Histology Studies on HPV and Other Viral Vaccinations: No Pathogenicity of HPV Vaccine Adjuvants

Cancer Science, EarlyView.
Anti‐HPV vaccine activists claimed that aluminum (Al) adjuvants in HPV vaccines could cause immune abnormalities, leading to neurological diseases. We evaluated the cytokine and histology profiles following administrations of HPV vaccines and other viral vaccines containing adjuvants.
Reona Shiro, Fumitaka Sato, Seiichi Omura, Ah‐Mee Park, Cong Thanh Nguyen, Ijaz Ahmad, Sandesh Rimal, Koji Kinoshita, Noriomi Matsumura, Ikuo Tsunoda   +9 more
wiley   +1 more source

Segmental vitiligo following nine-valent human papillomavirus vaccination: A case report. [PDF]

Hum Vaccin Immunother
Wang Z, Sun Y.
europepmc   +1 more source

Verrucous carcinoma of the larynx: Role of human papillomavirus, radiation, and surgery [PDF]

, 1993
Patrick C. Hagen, George D. Lyons, Christian J. Haindel   +2 more
openalex   +1 more source